All In MedTech

Device Trial Radar · NCT03992768

Feature Detection Study for Validation of Hamamatsu NanoZoomer S360MD Digital Slide Scanner System

Clinical Validation for Feature Detection Precision by WSI Using Hamamatsu NanoZoomer S360MD Digital Slide Scanner System

Last checked: Nov 20, 2026Latest source record: Dec 22, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

540

Actual

Start

Jun 12, 2019

Primary completion

Sep 30, 2021

Study completion Sep 30, 2021

Sponsor

Lead sponsor
Hamamatsu Photonics K.K.Not on our public-company list
Sponsor type
Industry
First posted
Jun 20, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to evaluate the repeatability and reproducibility of detection of histological features using whole slide imaging

Conditions

  • Pathology

Interventions

  • Hamamatsu NanoZoomer S360MD Digital Slide Scanner SystemDevice

    Detection of pathology features using whole slide imaging

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Percentage Agreement of Repeatability and Reproducibility Within Scanner, Between Scanners, and Sites.Time frame: 1 day

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Washington University

    St Louis, Missouri

  • The Cleveland Clinic Foundation

    Cleveland, Ohio

  • The Ohio State University

    Columbus, Ohio

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.